Here we demonstrated that knockdown of ASAP1-IT1 significantly suppressed cancer cell stemness of NSCLC cells and increase chemoresistance to cisplatin in NSCLC cells. The gene discussed is ASAP1; the disease is non-small cell lung carcinoma.